Related references
Note: Only part of the references are listed.Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes
Joao Delgado et al.
AGE AND AGEING (2021)
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults
Jessica E. Lockery et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study
Nandita Kachru et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis
Chao Zeng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
Emilia Schwertner et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)
Associations Between Potentially Inappropriate Medications and Adverse Health Outcomes in the Elderly: A Systematic Review and Meta-analysis
Xiao Xuan Xing et al.
ANNALS OF PHARMACOTHERAPY (2019)
How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study
Bryony Porter et al.
BMJ OPEN (2019)
Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study
Young-Mi Ah et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population
David T. Gamble et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study
Rachel Underlien Kristensen et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort
Shelly L. Gray et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia
Edwin C. K. Tan et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease
Heidi Taipale et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2017)
Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics
Amanda J. Cross et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea
Hae-Young Park et al.
PLOS ONE (2017)
Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population
Noll L. Campbell et al.
PHARMACOTHERAPY (2016)
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis
Kimberley Ruxton et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study
Sascha Dublin et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Sue Radcliff et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
Mohammed Saji Salahudeen et al.
BMC GERIATRICS (2015)
Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study
Phyo Kyaw Myint et al.
AGE AND AGEING (2015)
Association between Benzodiazepine Use and Dementia: A Meta-Analysis
GuoChao Zhong et al.
PLOS ONE (2015)
Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review
Terri R. Fried et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
Long-term Cognitive and Functional Effects of Potentially Inappropriate Medications in Older Women
Alain Koyama et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Association between polypharmacy and dementia in older people: A population-based case-control study in Taiwan
Shih-Wei Lai et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2012)
Risk of Cerebrovascular Adverse Events and Death in Elderly Patients With Dementia When Treated With Antipsychotic Medications: A Literature Review of Evidence
Vikrant Mittal et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2011)
STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
P. Gallagher et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study
Chris Fox et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Use of anticholinergics and the risk of cognitive impairment in an African American population
N. L. Campbell et al.
NEUROLOGY (2010)
Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population The 3-City Study
Isabelle Carriere et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Exposure to antipsychotics and risk of stroke: self controlled case series study
Ian J. Douglas et al.
BRITISH MEDICAL JOURNAL (2008)
The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening
Eneida Mioshi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials
LS Schneider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
